Anesthesiologists Recovering From Chemical Dependency: Can They Safely Return to the Operating Room?
Oreskovich, M. & Caldeiro, R. (2009). Anesthesiologists Recovering From Chemical Dependency: Can They Safely Return to the Operating Room? Mayo Clinic Proceedings. 84(7): 576-580.
A Double-blind, Double-dummy, Randomized, Prospective Pilot Study of the Partial MU Opiate Agonist, Buprenorphine, for Acute Detoxification From Heroin
Oreskovich, M., Saxon, A., Ellis, M., Malte, C., Reoux, J., & Knox, P. (2005). A double-blind, double-dummy, randomized, prospective pilot study of the partial MU opiate agonist, buprenorphine, for acute detoxification from heroin. Drug & Alcohol Dependence. 77, 71-79.
A Comparison of the CIWA-AR and the CIWA-AD in the Treatment of Alcohol Withdrawal
Reoux, J., & Oreskovich, M. (2006). A comparison of the CIWA-AR and CIWA-AD in the treatment of alcohol withdrawal. American Journal of Addictions. 15:1, 85-93.
Genetic Determinants of Addiction to Opioids and Cocaine
Brkanac, Z., Oreskovich, M., & Saxon, A. (2005). Genetic determinants of addiction to opioids and cocaine. Harvard Review of Psychiatry. 13:4, 218-232.
Risk Factors for Relapse in Health Care Professionals With Substance Use Disorders
Domino, K., Hornbein, T., Polissar, N., Renner, G., Johnson, J., Alberti, S., & Hankes, L. (2005). Risk factors for relapse in healthcare professionals with substance use disorders. JAMA. 293:12, 1453-1460.
Single Dose of 24 Milligrams of Buprenorphine for Heroin Detoxification: An Open-Label Study
Ang-Lee, K., Oreskovich, M., Saxon, A., Jaffe, C., Meredith, C., Ellis, M., Malte, C. & Knox, P. (2006). Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study. Journal of Psychoactive Substances. 38:4, 505-512
Sitemap 